FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Israel (Jurisdiction of incorporation or organization) OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 O ...

Tel Aviv, Israel, July 30, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" and the "Company"), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle ("EV") and charging solutions, announced today that it plans a ratio change which will result in a reverse split of the Company's American Depositary Receipt, or ADR, program on the basis of one (1) new ADS for every 2.666666 old ADSs held. As a result, the number of ordinary shar ...

Core Insights - Gix Internet Ltd. has signed a non-binding memorandum of understanding (MOU) with the shareholders of a robotics company specializing in AI autonomous robotics solutions for logistics in medical centers [9] - The shareholders of the Robotics Company will exchange their shares for 30% of Gix's issued and outstanding ordinary shares, with options to increase their holdings to 37.5% and 45% upon achieving specific commercial milestones [1][6] Company Overview - Xylo Technologies Ltd. is a technology-based company focused on innovative growth partnerships in advanced medical solutions, digital commerce, and electric vehicle markets [7] - Xylo holds a 45.75% stake in Gix Internet Ltd., which is involved in the current transaction with the Robotics Company [9] Transaction Details - The transaction will result in the Robotics Company becoming a wholly owned subsidiary of Gix, enabling Gix to pursue additional growth opportunities and technological advancements in AI and robotics [6] - The completion of the transaction is subject to customary closing conditions and the negotiation of a definitive agreement [1][6]

The new product offers unique capabilities of custom personalized text writing, different from common AI writing tools. TEL AVIV, Israel, May 28, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (Nasdaq: XYLO) ("Xylo"), a technology-based company engaged in advanced innovative technologies, announced today that Metagramm Software Ltd. ("Metagramm") (19.99% owned by Xylo), successfully completed development of Bubbl, an advanced writing tool utilizing Machine Learning, Natural Language Processing (NLP), Artif ...

The new product offers unique capabilities of custom personalized text writing, different from common AI writing tools. TEL AVIV, Israel, May 28, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (Nasdaq: XYLO) ("Xylo"), a technology-based company engaged in advanced innovative technologies, announced today that Metagramm Software Ltd. ("Metagramm") (19.99% owned by Xylo), successfully completed development of Bubbl, an advanced writing tool utilizing Machine Learning, Natural Language Processing (NLP), Artif ...

TEL AVIV, Israel, April 22, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo", or the "Company"), formerly known as Medigus Ltd., a technology-based company engaged in advanced innovative technologies, announced the filing of its 2023 Annual Report on Form 20-F with the Securities and Exchange Commission. Xylo's 2023 Annual Report on Form 20-F includes audited financial statements for the year ended December 31, 2023. The report can be accessed on the company's investor relations website ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commissi ...

Exhibit 99.1 MEDIGUS LTD. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2023 TABLE OF CONTENTS | Interim Condensed Consolidated Statements of Financial Position | 2 to 3 | | --- | --- | | Interim Condensed Consolidated Statements of Loss and Other Comprehensive Loss | 4 | | Interim Condensed Consolidated Statements of Changes in Equity | 5 to 6 | | Interim Condensed Consolidated Statements of Cash Flows | 7 to 8 | | Notes to Interim Condensed Consolidated Financial Statements | 9 to 57 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commissi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant's name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 4 ...